Novanta Inc. completed the acquisition of Riverpoint Medical from Arlington Capital Partners on July 23, 2026, for approximately $1.2 billion in cash, with a $250.0 million milestone payment due by January 8, 2027. To fund the transaction, the company borrowed $616.0 million under its revolving credit and delayed draw term loan facilities, bringing its total consolidated debt to $854.7 million. Novanta Inc. is a global supplier of core technology solutions for medical, life science, and advanced industrial original equipment manufacturers.
